Novartis
This article was originally published in The Tan Sheet
Executive Summary
Print ads will break in July for Lamisil AT Spray Pump and Solution Dropper (terbinafine hydrochloride 1%). The line extensions shipped May 19 (1"The Tan Sheet" March 27, p. 10). TV spots broke the week of June 18, and an FSI advertising "The best way to cure athlete's foot now in a targeted spray" dropped June 25. A third new product, Odor Guard deodorant foot powder, "From the makers of Lamisil AT," will be supported with dedicated promotions and advertising in health clubs. The spray pump and dropper will each retail for $9.99, the powder for $4.99
You may also be interested in...
Lamisil AT Spray Pump, Solution Dropper Line Extensions Launching June 1
Novartis Lamisil AT Spray Pump and Solution Dropper, both terbinafine hydrochloride solution 1%, are launching June 1, "just in time for the peak summer athlete's foot season," the firm said. FDA approved the Rx-to-OTC switch March 17. Novartis filed the NDA (21-124) for the topical solution with the agency May 14, 1999.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands